AbbVie: Citigroup Raises Target Price to $260 From $230
ABBV•Related News
Noah Holdings updates Hong Kong, mainland China dial-in numbers for Q2, H1 2026 earnings call
NOAH•
Zijin Gold International H1 FY26 profit attributable to owners jumps 179% to US$1.45 billion; revenue doubled to US$3.99 billion
GDX•
XBP Global releases transcript of 2Q26 earnings call
XBP•
BUZZ-Australia's American Rare Earths gains on signing MoU with Novex
XLB•
CAE Inc: RBC raises to outperform from sector perform; raises target price to C$46 from C$36
CAE•